Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benkert

Showing results (551-560 of 621) with videos related to

Pageof 63
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MSJens Kuhle, Nadia Daizadeh, Pascal Benkert, et al.
Annals of Neurology|October 11, 2024
Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple SclerosisGretel Sanabria-Diaz, Alessandro Cagol, Po-Jui Lu, et al.
Nucleic Acids Research|January 5, 2007
SYSTOMONAS--an integrated database for systems biology analysis of PseudomonasClaudia Choi, Richard Münch, Stefan Leupold, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2020
Monitoring of radiologic disease activity by serum neurofilaments in MSTomas Uher, Sabine Schaedelin, Barbora Srpova, et al.
Molecular Neurobiology|March 14, 2026
NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmaciesMaximilian Meyer, C Felix Mosandl, Adrian Guessoum, et al.
Journal of Neuroinflammation|May 2, 2021
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorderPatrick Schindler, Ulrike Grittner, Johanna Oechtering, et al.
Elife|July 6, 2022
β2-subunit alternative splicing stabilizes Cav2.3 Ca<sup>2+</sup> channel activity during continuous midbrain dopamine neuron-like activityAnita Siller, Nadja T Hofer, Giulia Tomagra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2023
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosisDavid Leppert, Mitsuru Watanabe, Sabine Schaedelin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 13, 2026
Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple SclerosisAlessandro Cagol, Pascal Benkert, Sabine Schaedelin, et al.
Breast Cancer Research and Treatment|May 30, 2015
HBOC multi-gene panel testing: comparison of two sequencing centersChristopher Schroeder, Ulrike Faust, Marc Sturm, et al.
Pageof 63

Showing results (551-560 of 621) with videos related to

Sort By:
Pageof 63
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MSJens Kuhle, Nadia Daizadeh, Pascal Benkert, et al.
Annals of Neurology|October 11, 2024
Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple SclerosisGretel Sanabria-Diaz, Alessandro Cagol, Po-Jui Lu, et al.
Nucleic Acids Research|January 5, 2007
SYSTOMONAS--an integrated database for systems biology analysis of PseudomonasClaudia Choi, Richard Münch, Stefan Leupold, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2020
Monitoring of radiologic disease activity by serum neurofilaments in MSTomas Uher, Sabine Schaedelin, Barbora Srpova, et al.
Molecular Neurobiology|March 14, 2026
NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmaciesMaximilian Meyer, C Felix Mosandl, Adrian Guessoum, et al.
Journal of Neuroinflammation|May 2, 2021
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorderPatrick Schindler, Ulrike Grittner, Johanna Oechtering, et al.
Elife|July 6, 2022
β2-subunit alternative splicing stabilizes Cav2.3 Ca<sup>2+</sup> channel activity during continuous midbrain dopamine neuron-like activityAnita Siller, Nadja T Hofer, Giulia Tomagra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2023
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosisDavid Leppert, Mitsuru Watanabe, Sabine Schaedelin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 13, 2026
Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple SclerosisAlessandro Cagol, Pascal Benkert, Sabine Schaedelin, et al.
Breast Cancer Research and Treatment|May 30, 2015
HBOC multi-gene panel testing: comparison of two sequencing centersChristopher Schroeder, Ulrike Faust, Marc Sturm, et al.
Pageof 63